RhumbLine Advisers’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.61M | Buy |
|
|||||
|
2025
Q2 | $754K | Buy |
|
|||||
|
2025
Q1 | $330K | Buy |
|
|||||
|
2024
Q4 | $545K | Buy |
|
|||||
|
2024
Q3 | $573K | Sell |
|
|||||
|
2024
Q2 | $647K | Buy |
|
|||||
|
2024
Q1 | $565K | Buy |
|
|||||
|
2023
Q4 | $215K | Sell |
|
|||||
|
2023
Q3 | $162K | Sell |
|
|||||
|
2023
Q2 | $448K | Buy |
|
|||||
|
2023
Q1 | $288K | Buy |
|
|||||
|
2022
Q4 | $316K | Buy |
|
|||||
|
2022
Q3 | $433K | Buy |
|
|||||
|
2022
Q2 | $421K | Buy |
|
|||||
|
2022
Q1 | $407K | Buy |
|
|||||
|
2021
Q4 | $431K | Sell |
|
|||||
|
2021
Q3 | $466K | Buy |
|
|||||
|
2021
Q2 | $588K | Buy |
|
|||||
|
2021
Q1 | $602K | Sell |
|
|||||
|
2020
Q4 | $971K | Buy |
|
|||||
|
2020
Q3 | $494K | Sell |
|
|||||
|
2020
Q2 | $402K | Sell |
|
|||||
|
2020
Q1 | $463K | Buy |
|
|||||
|
2019
Q4 | $225K | Buy |
|